Technical / White Paper

Pharmaceutical Development for ADCs

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Baxter BioPharma Solutions, and any views and opinions expressed do not necessarily reflect those of

Pharmaceutical Development for ADCs

Formulation, process, and analytical development for antibody-drug conjugates, or ADCs, is complex.

While the development of an aqueous solution formulation may be preferred over a lyophilized product, it is useful to initially pursue a dual path and develop drug product formulations for both a sterile solution and a freeze-dried solid presentation, ultimately choosing the most successful candidate for final development.

This white paper provides an overview of:

  • ADC structure and function
  • The development process
  • Lyo cycle optimization 

Related resources from Baxter BioPharma Solutions

Supplier info centre